コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 per kilogram of body weight was administered bimonthly.
2 s varied considerably, ranging from daily to bimonthly.
3 Infants' weight and length were measured bimonthly.
4 trough concentrations (Cmin) for monthly and bimonthly administration were calculated for various BMI
5 arget concentration at steady-state with the bimonthly administration, but this was less frequent wit
7 ation 1 and 2 trials showed that monthly and bimonthly aflibercept were noninferior to monthly ranibi
8 opioid use in both groups and abstinence at bimonthly and random call-back visits, treatment adheren
9 sts, donor-type cells in blood were measured bimonthly and the resulting repopulation kinetics were g
10 tory of Depressive Symptoms was administered bimonthly, and rates of clinically significant symptom e
12 authors met in person and by teleconference bimonthly between 2014 and 2018 to develop and revise th
15 o Reduce Opioid Prescribing (CROP), entailed bimonthly, comparative, and practice-individualised feed
18 ates were also observed at TAB participants' bimonthly dosing visits (83.0% [95% CI, 67.0%-92.0%] for
19 nt was done at baseline, post-treatment, and bimonthly during the maintenance period from 8 to 12 mon
21 servational trials, characterized by regular bimonthly (every other month) in-person clinical assessm
22 in plus fluorouracil/leucovorin administered bimonthly (FOLFOX4) in patients age younger than and at
24 icipants completed a baseline questionnaire, bimonthly follow-up questionnaires (until pregnancy or a
26 use, and medical history; females completed bimonthly follow-up questionnaires for up to 12 months.
27 follow-up questionnaires, and they completed bimonthly follow-up questionnaires until self-reported p
31 precision, we analyzed soybeans and soymilk bimonthly for within-day precision and over 4 d for day-
33 o 17 years underwent baseline assessment and bimonthly guideline-based management visits over 1 year.
34 nrollment (visit 0 [V0]) and after 1 year of bimonthly guidelines-based management visits (visit 6 [V
35 rch using actively detected malaria cases in bimonthly household surveys carried out from April 2012
36 d 6-month intervals compared with monthly or bimonthly injections were calculated using Medicare rate
39 hibitor (INSTI), reduces dosing frequency to bimonthly injections, variable pharmacokinetics (PK) bet
47 This case report describes the effects of bimonthly long-acting injectable cabotegravir (CAB)/RPV
48 SD] age, 47.04 [1.41] years; 51.04% female), bimonthly mean (SD) numbers of average-risk beneficiarie
50 n IV infusion (10-40 mg/kg) given monthly or bimonthly, or as an SC injection (5 mg/kg) every 2 weeks
55 an number of eligible beneficiaries for each bimonthly period was 8 087 565 (range, 6 407 602-8 747 3
63 ceive usual care, a behavioral intervention (bimonthly tailored, nurse-administered telephone interve
70 val [CI], 4.9-8.3), and after institution of bimonthly treatment the mean change in BCVA at month 12